Related Experiment Videos

Aminophylline aggravates long-term morphological and cognitive damages in status epilepticus in immature rats

Li-Tung Huang1, Chia-Wei Liou, San Nan Yang

  • 1Department of Pediatrics, Chang Gung Memorial Hospital, 123, Ta-Pei Road, Niao-Sung, Kaohsiung, Taiwan. huang_li@taiwan.com

Neuroscience Letters
|March 7, 2002
PubMed

Insights

Aminophylline, an apnea treatment, worsened seizures and brain damage in developing rats. Adenosine receptor antagonists may exacerbate seizure-induced injury in young brains.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Developmental Biology

Background:

  • Status epilepticus (SE) is a severe neurological condition.
  • The developing brain's response to SE and potential drug interactions require further investigation.
  • Aminophylline is an adenosine receptor antagonist used for apnea.

Purpose of the Study:

  • To investigate the synergistic effects of aminophylline on status epilepticus in the developing brain.
  • To determine if aminophylline exacerbates seizure-induced damage and cognitive deficits.

Main Methods:

  • Rats were treated with saline, aminophylline, lithium-pilocarpine (Li-PC), or Li-PC plus aminophylline on postnatal day 14.
  • Behavioral testing (Morris water maze) was conducted at P80.
  • Histological analysis (cresyl violet and Timm stain) assessed brain lesions and mossy fiber sprouting.

Main Results:

  • Aminophylline alone did not induce seizures.
  • Both Li-PC and Li-PC plus aminophylline groups exhibited seizures.
  • Aminophylline aggravated spatial memory deficits and histological brain damage in Li-PC-treated rats at adulthood.

Conclusions:

  • Adenosine receptor antagonists, such as aminophylline, can exacerbate seizure-induced damage in the developing brain.
  • These findings suggest caution when using aminophylline in contexts involving developing brains and seizure activity.

Related Concept Videos